While it's an issue that's not limited to the pharmaceutical industry, miscommunication between the "doers" - those actually performing clinical trials - and the "planners," who set and monitor the budget, is particularly prominent. While research and development in a non-pharmaceutical business can often be put on indefinite hold while funding is secured, clinical trials don't share that luxury. Variables such as timing, resources, and the ability to make adjustments if obstacles arise are freedoms all crucial to a given trial's success. This means, in turn, that "holding" isn't really a viable option. So how can the behind-the-scenes program teams work in tandem with those on the front lines?
Read MoreCBI Scene Blog
How to Align Management with Functional Areas of R&D
Posted by Evanna Payen on Apr 11, 2018 9:39:01 AM
Topics: Clinical, Compliance, Finance
Why Attend Medicaid 2014? The Reasons Are Endless...
Posted by Logan Fleck on May 13, 2014 10:43:00 AM
The Medicaid and Government Pricing Congress is one of the industry’s largest gatherings of managers and executives responsible for Contracts, Pricing, Finance, Accounting and Government Program Compliance. Over the past 15 years, almost 3,000 attendees have benefited from this valuable conference, which brings real world topics — including Healthcare Reform, Medicaid Expansion, Exchanges, Gross-to-Net, VA/DoD, 340B and Compliance — all into one forum. The session content and quality of presenters are always outstanding, and the opportunities to network with industry peers are invaluable.
Topics: Finance
Leverage Technological Advancements to Achieve Financial Transformation
Posted by Sarah S on Feb 26, 2014 1:28:00 PM
Topics: Finance
Evolving Pharma Accounting Challenges in the International Arena
Posted by Katie S on Jan 31, 2014 4:08:00 PM
Topics: Finance
Creating & Maintaining the ‘Standard’: 5 Ways to Enhance Your GTN Performance
Posted by Leigh Anne Siino on Nov 27, 2013 2:39:00 PM
Topics: Finance
Harry Potter’s Severus Snape & Big Pharma, a Comparison
Posted by Daria Binder on Sep 18, 2013 11:25:00 AM
Topics: Brand & Digital Strategy, Medical Affairs, Patient Access, Distribution and Channel, Compliance, Finance
Musings on the AMP Final Rule & Other Fun Tidbits from Steven Moore
Posted by Jamie McHugh on May 3, 2013 12:08:00 PM
Topics: Government Pricing, Finance
Medical Device Excise Tax (MDET) Conversation Intensifies
Posted by Brittany Lake on Mar 29, 2013 11:23:00 AM
Topics: Compliance, Finance